CLINICAL_TRIALS
trial_result
· 2015-08-19
Clinical Trial Update: Safety Study of Albuterol Spiromax® in Subjects With Asthma [Phase 3]
Summary
A Phase 3 safety study of Albuterol Spiromax in subjects with asthma has been completed; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2015-08-19